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INTRODUCTION
The maintenance of a functional and fully potent pool of hematopoietic stem cells (HSCs) is essential to sustain continuous blood production and enable recovery of the hematopoietic system after an insult (Bryder et al., 2006; Weissman, 2000) . However, despite the enormous cellular turnover needed to ensure appropriate hematopoiesis, HSCs themselves are typically highly quiescent, which is a feature that offers protection against various types of stress-induced damage that can otherwise be caused by continuous replication and cellular respiration (Eliasson and Jö nsson, 2010) . By contrast, HSCs can be rapidly mobilized to proliferate and reconstitute the hematopoietic system upon an insult. At a molecular level, these critical processes are regulated by defined transcription factors, and studies using genetically modified mice or translocations causing human leukemia have established transcription factor networks that critically influence HSC fate options (Orkin and Zon, 2008) .
Hepatic leukemia factor (HLF), a member of the proline and acidic amino-acid-rich (PAR) basic leucine zipper (bZip) family, was originally identified as part of the t(17:19)(E2A-HLF) translocation, which underlies a rare subtype of pediatric acute lymphoblastic leukemia (ALL) (Inaba et al., 1992) . In contrast to most ALL types, the E2A-HLF subtype is chemotherapy resistant and associated with high mortality, usually within 2 years of the diagnosis (Hunger et al., 1992; Inukai et al., 2007) . In addition, more recent transcriptional profiling studies have implicated HLF as a ''stemness'' gene in both normal and malignant hematopoiesis (Dorn et al., 2009; Gazit et al., 2013; Ivanova et al., 2002; Magnusson et al., 2013; Moore et al., 2007; Shojaei et al., 2005) , as HLF is highly expressed in the HSC pool and gradually downregulated upon differentiation (Gazit et al., 2013) .
In hematopoiesis, ectopic expression of HLF alone was shown to increase engraftment of human cord blood cells and improve multi-lineage potential and self-renewal of HSC in vitro (Gazit et al., 2013; Shojaei et al., 2005) . Moreover, Riddell et al. recently found HLF to be one of six transcription factors that together are capable of reprogramming B cells into HSC-like cells in vivo (Riddell et al., 2014) . Thus, enforced expression of HLF is strongly associated with enhanced HSC activity in both humans and mice, yet whether endogenous HLF plays a physiological role in HSC regulation has not been assessed.
Here, using HLF-knockout mice, we show that HLF deficiency causes a gradual depletion of HSC activity during serial repopulation. Moreover, HLF-deficient HSCs display a loss of quiescence and show increased sensitivity to chemotoxic insult or irradiation. Our findings therefore depict an essential role for HLF in preserving HSC quiescence.
RESULTS

HLF Is Dispensable for Steady-State Hematopoiesis
To investigate the physiological role of HLF in hematopoiesis, we first determined its expression pattern in isolated hematopoietic stem and progenitor cell populations from mouse bone marrow (BM) by real-time qPCR. The analysis showed that HLF is highly and preferentially expressed in HSCs and multipotent progenitors and less expressed in more committed progenitor populations ( Figure 1A ), consistent with previous transcriptome profiling studies (Gazit et al., 2013; Ivanova et al., 2002) . Next, to assess the functional consequences of HLF deficiency on hematopoiesis, we employed a conventional knockout mouse model for Hlf (Gachon et al., 2004) . The Hlf À/À mice were fertile and born at a normal Mendelian ratio (data not shown). At 12-16 weeks of age, Hlf À/À mice displayed normal body weight (data not shown), as well as normal cellularity of both BM and spleen (Figures 1B and 1C) . Peripheral blood (PB) analysis revealed no significant changes in the blood cell counts of Hlf À/À mice, with the exception of reduced platelet numbers ( Figure 1D ).
To investigate whether the observed bias in platelets is a result of perturbed differentiation capacity, we analyzed the early stages of megakaryopoiesis potential using flow cytometry. While the relative proportions of pre-MegE (common megakaryocyte/ erythroid progenitor) and pre-CFU-E (erythroid restricted progenitor) cells were unchanged, we observed a significant reduction in phenotypic MkP (megakaryocyte restricted progenitor), suggesting that HLF deficiency results in a reduced differentiation capacity specifically toward platelets ( Figure S1 ). Additional evaluations by flow cytometry showed a normal frequency and distribution of mature blood cells in both PB and BM (Figures 1E and 1F) . Taken together, these data show that mice can sustain essentially normal hematopoietic parameters in the absence of HLF.
Since (Figure 2A) . PB analysis at 8 and 16 weeks post-transplantation showed a significant reduction in the donor contribution (chimerism) of the Hlf À/À cells in comparison to Hlf +/+ cells ( Figure 2B ), although no change in lineage distribution was observed ( Figures 2C and 2D) . At 16 weeks post-transplantation, the BM of engrafted mice was analyzed. This revealed a similar reduction in the chimerism of Hlf À/À HSC-derived cells as seen in the PB analysis ( Figure 2E ). Of note, the reduction was more pronounced in the LSK population that contains HSC and progenitor cells, indicating that the role of HLF is more important for immature cells ( Figure 2E ). To address whether HLF deficiency specifically impairs the self-renewal capacity of HSCs, BM cells from the primary recipients were serially transplanted to secondary and tertiary recipients (Figures 2F and 2G) . BM analysis showed that the reduced reconstitution capacity seen in the primary recipients of the Hlf À/À BM cells was even more pronounced in secondary recipients ( Figure 2F ), with dismal reconstitution detected in tertiary recipients ( Figure 2G ). This establishes that HSC activity is compromised during regenerative conditions in the absence of HLF.
To investigate whether the reduced long-term engraftment capacity is caused by an overall reduction of the HSC pool size, competitive repopulation units (CRUs) were quantified by transplanting limited doses of Hlf +/+ or Hlf À/À BM in a competitive setting ( Figure 2H Figure 2I ). Analysis at 16 weeks post-transplantation showed a reduction in reconstitution capacity similar to that seen in unfractionated BM ( Figure 2J ), strongly arguing for a reduced regenerative potential of Hlf
HSCs on a per-cell basis. Taken together, the results of the transplantation experiments demonstrate that expression of HLF is crucial for HSCs to maintain their self-renewal potential during hematopoietic reconstitution.
Gene Expression and ChIP-Seq Analysis Suggest that HLF Regulates HSC Cell-Cycle Activity Since previous findings have shown that overexpression of HLF results in a pro-survival effect (Shojaei et al., 2005; Waters et al., 2013) , we asked whether the impaired reconstitution capacity of Hlf À/À HSCs is due to increased apoptosis. However, evaluations of Annexin-V failed to reveal a significant difference in the frequency of apoptotic cells between Hlf À/À and Hlf +/+ LSK cells ( Figure 3A ), implying the involvement of other mechanisms. (Table S1 ). Among the downregulated genes, we identified transcription factors known to be important for maintaining normal HSC activity (GFI1 and IRF2) (Hock et al., 2004; Sato et al., 2009 ), while among the upregulated genes, we identified several genes known to regulate cell-cycle activity (Table S2) . By applying Gene Ontology (GO) analysis on the differentially expressed genes, we revealed a significant enrichment of cell cycle, DNA replication, and cellular stress response genes among the genes upregulated in Hlf À/À HSCs ( Figure 3B ; Table S2 ).
Similarly, gene set enrichment analysis (GSEA) showed that the upregulated genes in Hlf À/À HSCs were significantly associated with gene sets related to cell cycle and DNA replication (Figure 3C) . In line with this, the transcriptome of the Hlf À/À HSCs significantly correlated to the transcriptome of short-term HSCs (ST-HSCs) (a set of genes extracted that are known to be more mitotically active than long-term HSCs (LT-HSCs); Ficara et al., 2008) (Figures 3D and 3E) .
To determine whether HLF directly binds to regulatory elements of genes regulating HSC activity, we obtained chromatin immunoprecipitation sequencing (ChIP-seq) data from mouse LSK cells overexpressing Hlf (Wahlestedt et al., 2017) . The dataset identified 693 genes bound by HLF, with a binding motif similar to the known HLF-binding site described in Wahlestedt et al. (2017) .
Intersection of the ChIP-seq data with the transcriptome data based on fold change, irrespective of the q value, revealed that more than 30% of HLF-bound genes (229 out of 693) were transcriptionally modulated in Hlf À/À HSCs ( Figure S2 ). This suggests that a substantial number of the modulated genes from the RNA sequencing (RNA-seq) analysis are direct targets of HLF. Among the overlapping genes, we observed two distinct clusters, one with upregulated and one with downregulated genes. This suggests that HLF may act both as an activator and a repressor in the HSC context. GO analysis of the overlapping genes revealed an enrichment of gene sets regulating cell activity and stress response among the upregulated genes, while the downregulated genes were enriched for transcriptional regulation (data not shown). By overlapping ChIP targets with the significantly regulated genes, we identified a set of transcription factors that were all downregulated in Hlf À/À HSCs ( Figure 3F ). Among these transcription factors, we found Nfic (identified as a direct target of HLF in Wahlestedt et al., 2017) and Irf2, which is an important regulator of HSC quiescence (Sato et al., 2009 ) ( Figure 3F ). When intersecting the HLF-binding data with ChIP-seq data of active histone marks in HSC and assay for transposase-accessible chromatin (ATAC) sequencing data in LSK cells (Wahlestedt et al., 2017) , we could confirm that HLF directly binds to the promoter region (surrounded by active histone marks) as well as to possible enhancer regions of Irf2 ( Figure 3G ). This suggests that HLF directly promotes the transcription of Irf2 in HSCs. Taken together, these data suggest that HLF is important in regulating HSC quiescence and that HLF may act as both a repressor and an activator of gene function in HSCs. 
HLF Deficiency Causes a Loss of HSC Quiescence
To functionally confirm findings from RNA and ChIP-seq, we performed cell-cycle analysis. These experiments revealed that while the majority (65. HSCs. Interestingly, gene expression analysis revealed that CD48, which is normally expressed in less primitive and more activated hematopoietic progenitor cells (Kiel et al., 2005) , was upregulated in Hlf À/À HSCs (Table S1 ) and bound by HLF in ChIP-seq ( Figure S2 ). Using flow cytometry, we confirmed that the LSK CD48 this, we therefore studied the response of Hlf À/À HSCs to transient hematopoietic stress induced by the myeloablative agent 5-fluorouracil (5-FU), which preferentially eliminates actively cycling cells ( Figure 5A ). Strikingly, Hlf À/À mice receiving 5-FU were unable to recover from the severe myelosuppression induced by the drug, and none of these mice survived treatment ( Figures 5B and S4A ). This outcome was reflected in the BM profile by a complete loss of the LSK population that, unlike the situation in control animals, failed to recover ( Figure 5C ). To exclude the possibility that the increased sensitivity to 5-FU was influenced by toxicity to other, non-hematopoietic tissues, we transplanted Hlf À/À or Hlf +/+ BM cells to irradiated wild-type (WT) recipient mice. First, we analyzed their blood parameters, which mirrored the levels seen at steady-state hematopoiesis ( Figure S4B ). Following complete BM reconstitution of donor cells, the mice were challenged by 5-FU treatment ( Figure 5D ). Mice reconstituted with Hlf À/À cells did not survive 5-FU treatment ( Figures 5E and S4C ) and showed a complete loss of the HSC compartment ( Figure 5F ), demonstrating that the increased sensitivity to 5-FU is indeed intrinsic to hematopoietic cells. Finally, since the PAR bZip family is known to regulate xenobiotic metabolism in hepatic cells (Gachon et al., 2006) , we wondered whether the more severe BM failure induced by 5-FU treatment in the Hlf À/À mice was due to defective drug metabolism. To address this, we used sublethal irradiation as an alternative, non-pharmacological, toxic insult to target dividing cells ( Figure 5G ). Similar to 5-FU treatment, Hlf À/À mice showed significantly lower survival after exposure to sublethal irradiation ( Figures 5H and S4D) . Moreover, 12 days post-irradiation, Hlf À/À mice displayed a dramatic reduction of hematopoietic progenitor cells compared to control mice ( Figure 5I ). Taken together, these results strongly imply that HLF is crucial for protecting HSCs from toxic insults by preserving their quiescent state.
DISCUSSION
HLF has been suggested as an important regulator of HSC function when ectopically expressed, but until now, the physiological role of HLF in HSC biology has remained unknown. Here, using HLF knockout mice, we demonstrate that HLF is essentially dispensable for hematopoiesis under steady-state conditions. However, HLF-deficient HSCs were found to reside in a more ''active'' (less quiescent) state, both transcriptionally and functionally, and upon serial transplantation showed reduced reconstitution capacity and impaired self-renewal potential. Moreover, HLF-deficient mice demonstrated an increased sensitivity to treatment with cytotoxic drugs and sublethal irradiation, which eradicated the hematopoietic stem/progenitor cell pool and severely reduced the survival of Hlf À/À mice. In addition, CD48 and CD150 were identified as direct targets of HLF. In accordance with this, no HSCs were present within the classical LSK CD48 + CD150 À population in Hlf À/À mice, even though the HSC pool size was not altered. Our findings strongly suggest that HLF is an essential regulator of HSC quiescence and that HLF deficiency leads to an exhaustion of HSCs in adult mouse BM during regeneration or following cytotoxic stress. In line with this, genome-wide expression analysis of Hlf À/À HSCs overlapped with ChIP-seq analysis not only revealed general patterns associated with increased cell cycling and activation but also identified a number of known HSC regulators (some directly bound by HLF) that were significantly altered and that may provide further mechanistic insight into the enhanced cell-cycle progression. For example, the transcriptional repressors GFI1 and IRF2, whose deficiency has been reported to result in HSC exhaustion due to loss of HSC quiescence in adult hematopoiesis (Hock et al., 2004; Sato et al., 2009; Zeng et al., 2004) , were found to be downregulated in Hlf À/À HSCs, akin to the Hlf À/À phenotype. Interestingly, GFI1
has been shown to be regulated by LMO2 (Cheng et al., 2016) , which is a known target gene of the E2A-HLF fusion protein (de Boer et al., 2011; Yamada et al., 1998) . These findings indicate a potential regulatory axis linking HLF, GFI1, and LMO2, and it would be interesting to further study the connection between LMO2 and GFI1 in Hlf À/À HSCs.
In addition, we found that HLF binds to the promotor of IRF2 and that the binding site was surrounded by active histone marks, indicating that HLF promotes the expression of Irf2 in HSCs. This is in line with the significant reduction in gene expression of Irf2 detected in Hlf À/À HSCs. Given its important role in HSC regulation, Irf2 could be a major contributor to the loss of HSC quiescence detected in Hlf À/À mice. In fact, Irf2 À/À HSCs were found to be highly proliferative and failed to engraft in competitive repopulation assays (Sato et al., 2009) . Interestingly, IRF2 is known to suppress interferon (IFN) signaling, which is elevated during stress, and strikingly, it was shown that HSC function in Irf2 À/À mice was restored by disabling IFN signaling (Baldridge et al., 2010; Brzostek-Racine et al., 2011; Sato et al., 2009) . These data suggest that HLF may protect HSCs from exhaustion triggered by stress responses from the immune system. In an alternative scenario, HLF may be directly involved in structuring the HSC-specific gene network, with the reduced quiescence being a result of the loss of stem cell potential. While this would, in a traditional view, argue that HLF-deficient mice are unable to sustain normal hematopoiesis long-term, recent studies have suggested that HSCs may have limited contribution to adult steady-state hematopoiesis (Busch et al., 2015; Sun et al., 2014) , with only marginal effects on hematopoiesis observed even upon severe and irreversible HSC depletion (Schoedel et al., 2016) . A potential loss in stem cell potency in the HLF-deficient setting may therefore be compatible with normal steady-state hematopoiesis and only become evident during immediate settings of regeneration or toxic stress. This correlates with the downregulation of HLF during normal HSC differentiation (Gazit et al., 2013) and to the decline of HLF upon in vitro culture (Magnusson et al., 2013) , events that are both connected to compromised stem cell activity. Reciprocally, enforced expression of HLF in both mouse and human HSCs prolonged their in vitro self-renewal capacity (Gazit et al., 2013; Calvanese et al., 2014) , with an essential contribution of HLF for successful in vivo reprogramming of B cells into induced HSCs (iHSCs) (Riddell et al., 2014) , further implying a critical role of HLF in the gene regulatory networks governing HSC fate options.
In conclusion, we link the primary hematopoietic phenotype of HLF knockout mice directly to HSCs, in accordance with the unique expression pattern of HLF in hematopoiesis. Thus, HLF appears to be primarily required for HSC integrity in adult hematopoiesis. In this manner, HLF provides an important entry point in unraveling the molecular mechanisms regulating HSC identity and quiescence.
EXPERIMENTAL PROCEDURES
Mice C57BL/6 (CD45.2), B6SJL (CD45.1), and C57BL/6 3 B6SJL (CD45.1/CD45.2) mice were maintained in individually ventilated racks and given autoclaved food and water ad libitum. The generation of the Hlf À/À mice (obtained from the European Mouse Mutant Archive) was previously described (Gachon et al., 2004) , and mice were backcrossed to C57BL/6 on-site. All experiments were performed using mice at 9-16 weeks of age of any gender. All mice were maintained according to Swedish animal guidelines at the Lund University animal facility, and all animal experiments were performed with consent from the local ethical committee (ethical permit M94-15).
Real-Time qPCR
Total RNA was isolated from fluorescence-activated cell sorting (FACS)-sorted cells using the RNeasy micro kit (QIAGEN) and reverse transcribed (SuperScript III, Invitrogen) in the presence of random hexamers. Real-time PCRs were performed on 7900HT Fast Real Time PCR system (Applied Biosystems) according to the manufacturer's protocol with gene-specific primers (Applied Biosystems) and SDS 2.2.1 software. Each assay was performed in triplicate, and the results were normalized to the housekeeping gene hypoxanthine guanine phosphoribosyl transferase (Hprt).
PB and Bone Marrow Preparation
PB was collected from the tail vein using microvette tubes (Sarstedt) and kept in heparin (2,000 IU/mL; Leo Pharma). Blood parameters were analyzed using SysmexXE-5000 (Sysmex Eurpoe). Before antibody staining of the PB, erythrocytes were lysed twice with 150 mM ammonium chloride (NH 4 Cl; STEMCELL Technologies) for 10 min at room temperature. Bone marrow (BM) cells were isolated by crushing femur and tibia from each mouse in PBS containing 2% fetal calf serum (FCS) (Gibco). Cells were passed through a nylon filter (70 mm; BD Biosciences) to obtain single-cell suspensions.
Flow Cytometry Analysis
For lineage analysis, cells were stained with the combinations of fluorochrome-conjugated monoclonal antibodies for cell-surface markers for 30 min in darkness on ice. For stem and progenitor cell sorting purposes, BM cells were lineage depleted using anti-lineage microbeads with the MACS separation column (Miltenyi Biotec) according to manufacturer protocol, followed by staining with the combinations of fluorochrome-conjugated monoclonal antibodies. 7-Aminoactinomycin D (7-AAD; Invitrogen) or propidium iodide (Invitrogen) was used to exclude dead cells. All experiments were performed using FACS Canto, FACS LSR II cytometers, FACS Aria IIu, or FACS Aria III cell sorters (Becton Dickinson) and analyzed by FlowJo software (Tree Star, version 9.5.1 or 10.0.2). Antibodies used in analyses are listed in Table S4 . competitor cells. The cell dose was considered to contain at least one CRU if donor engraftment in the BM exceeded 1% of both lymphoid and myeloid lineages. The CRU frequency was calculated and plotted using extreme limiting dilution analysis (ELDA) as previously described (Hu and Smyth, 2009 ).
Apoptosis Assay BM cells prestained for HSC markers were stained with phycoerythrin (PE)-conjugated Annexin-V and 7-AAD (BD Biosciences) according to the manufacturer's protocol. Annexin-V binding and 7-AAD incorporation were measured using FACS Canto II.
Cell-Cycle and Cell Proliferation Analysis
For in vitro cell-cycle analysis, the PE Mouse Anti-Ki-67 Set (BD Biosciences) was used. Fresh BM cells were stained with the antibody cocktail for the HSC fraction. Cells were then fixed and permeabilized using the BD Cytofix Cytoperm Fixation kit (BD Biosciences) and stained with anti-Ki67 according to the manufacturer's protocol. Cells were analyzed for Ki67 expression and 7-AAD incorporation using flow cytometry. For in vivo cell-cycle analysis with BrdU, the APC BrdU Flow kit (BD Pharmingen) was used. Mice received a single intraperitoneal injection of 1 mg BrdU per recipient. After 1 hr, mice were euthanized, and BM cells were stained with antibody cocktail for the HSC fraction, fixed and permeabilized according to the manufacturer's protocol, and analyzed by flow cytometry.
For in vivo labeling with BrdU, mice were intraperitoneally injected with 1 mg BrdU per mouse for 3 days and then euthanized 3 hr after the last injection. BM cells were prepared according to the manufacturer's protocol and analyzed by flow cytometry.
5-FU Treatment and Sublethal Irradiation
Steady-state mice or fully reconstituted mice (16 weeks post-transplantation) transplanted with either Hlf +/+ or Hlf À/À BM cells were intravenously injected once with 5-FU (APP Pharmaceuticals) at 150 mg/kg body weight. To give a sublethal dose of radiation, the mice were irradiated with 350 cGy total body radiation.
RNA-Seq and ChIP-Seq Analyses
Total RNA was isolated from 3,000 sorted LSK CD34 À Flt3 À cells using the QIAshredder and RNeasy Mini Kit (QIAGEN). RNA libraries were constructed by the UCLA Clinical Microarray Core, Los Angeles, using TruSeq kits (Illumina). The RNA libraries were sequenced on a HiSeq 2000/2500 at 2 3 100 bp. Transcript levels were estimated using the method RSEM (RNA-seq by expectation maximization) (Li and Dewey, 2011) . Reads were mapped using bowtie2 method to the mouse RefSeq transcripts obtained from University of California, Santa Cruz (UCSC) (Speir et al., 2016) . Pairwise differential expression assessments were performed using the method EBSeq (Leng et al., 2013) ; genes were considered to be differentially expressed based on a false discovery rate of less than 5% (posterior probability of being differentially expressed < 0.05). GO analysis was performed using DAVID. GSEA was performed using the method GSEA Preranked. All p and false discovery rate (FDR) q values were calculated as described previously (Mootha et al., 2003) . Ranked lists of genes with a fold change of greater than 1.5 were used as input for GSEA preranked. The enrichment plots were obtained using curated gene sets in GSEA MSigDB and were obtained by adding the costume made gene sets (generated from GEO: GSE9189 by comparing LT-HSC and ST-HSC p < 0.01 and fold-change threshold of 2 as a filter) to the curated gene sets in GSEA MSigDB. ChIP-seq was performed as described previously (Wahlestedt et al., 2017) . Briefly, peak regions were called using MACS2 (Zhang et al., 2008) and density plots generated in bigwig format. These were then displayed together as custom tracks on the UCSC Genome Browser. Peaks were assigned to genes if the peak was (1) in a promoter according to MPromDB (Gupta et al., 2011) , (2) not in a promoter but intragenic, or (3) neither in a promoter nor intragenic but intergenic within 50 kb from the start or end of a gene. Motif discovery was performed using the HOMER program (Heinz et al., 2010) . The HLF-bound genes identified in ChIP-seq were used to generate the HLF network in Cytoscape 3.0.0. To explore the gene expression status of HLF-bound targets, we overlaid the RNA-seq data derived from Hlf À/À mice. Differentially expressed genes (with p values < 0.1) were also overlaid with the HLF network to identify the enriched targets. To visualize genome data, we used the UCSC Genome Browser.
Statistical Analyses
Graphs were generated using GraphPad (Prism Version 7 software). MannWhitney or Student's t test was used to determine statistical significance, and 2-tailed p values are shown (significance levels: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001). All error bars represent SEM.
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